Minimally invasive 99mTc-Sestamibi radioguided surgery of parathyroid adenomas

Panminerva Medica

Volumn 47, Issue 2, 2005, Pages 99-107

  Rubello, D ^a,d   Giannini, S ^b   De Carlo, E ^b   Mariani, G ^c   Muzzio, P C ^b   Rampin, L ^a   Pelizzo, M R ^b  

^a Rovigo Hospital   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Hyperparathyroidism; Minimally invasive surgery; Parathyroidectomy; Radioguided parathyroidectomy; Scintigraphy; Technetium Tc 99m sestamibi

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADENOMA; HUMAN; MINIMALLY INVASIVE SURGERY; PARATHYROID TUMOR; REVIEW; SCINTISCANNING;

ADENOMA; HUMANS; PARATHYROID NEOPLASMS; RADIOPHARMACEUTICALS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNETIUM TC 99M SESTAMIBI;

EID: 27744584347     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Clark OH. Surgical treatment of primary hyperparathyroidism. Adv Endocrinol Metab 1995;6:1-16.
2. Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyrodism: Consensus development conference statement. Ann Intern Med 1991;114:593-7.
3. Bilezikian JP, Potts JT. Asymptomatic primary hyperparathyrodism: new issues and new questions: brindging the past with the future. J Bone Min Res 2002;17: N57-N68.
4. LiVolsi VA, Hamilton R. Intraoperative assessment of parathyroid gland pathology. A common view from the surgeon and the pathologist. Am J Clin Pathol 1994;102:365-73.
5. Kaplan E, Barlett S, Sugimoto J, Fredland A. Relation of postoperative hypocalcemia to operative technique: deleterious effect of excessive use of parathyroid biopsy. Surgery 1982; 92:827-34.
6. Lo Gerfo P. Bilateral neck exploration for parathyroidectomy under local anesthesia: a viable technique for patients with coexisting thyroid disease with or without sestamibi scanning. Surgery 1999;126:1011-5.
7. Jaskowiak N, Norton JA, Alexander HR, Doppman JL, Shawker T, Skarulis M et al. A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg 1996;3:308-22.
8. Tibblin S, Bondeson AG, Ljubgberg O. Unilateral parathyroidectomy in hyperparathyroidism due to a single adenoma. Ann Surg 1982;195:245-52.
9. Norman J, Chheda H. Minimally invasive parathyrodiectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998-1003.
10. Miccoli P, Bendinelli C, Berti P, Vignali E, Pinchera A, Marcocci C. Video-assisted versus conventional parathyroidectomy in primari hyperparathyroidism: a prospective randomized study. Surgery 1999;126:1117-21.
11. Irvin GL, Dembrow VD, Prudhomme DL. Clinical usefulness of an intraoperative "quick PTH" assay. Surgery 1993;114:1019-23.
12. Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 2002;137:1055-9.
13. Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collings REC. 99mTc-sestamibi: a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-4.
14. O'Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-Sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33:313-8.
15. Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium 99m pertechnetate/sestamibi subtraction, a double phase technetium 99m sestamibi and technetium sestamibi SPECT. J Nucl Med 1997;38:834-9.
16. Hindié E, Melliere D, Jeanguillaume C, Perlemuter L, Chehade F, Galle P. Parathyroid imaging using simultaneous double-window recording of Technetium-99m-sestamibi and iodine-123. J Nucl Med 1998;39:1100-5.
17. Moka D, Voth E, Dietlein M, Larena-Avellanda A, Schicha H. Technetium 99m-MIBI SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000;128:29-35.
18. Rubello D, Saladini G, Casara D, Piotto A, Toniato A, Pelizzo MR. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy. A fast and effective technique. Clin Nucl Med 2000;25:527-31.
19. Borley NR, Colins REC, O'Doherty M, Coakley A. Technetium-99m-sestamibi parathyroid localization is accurate enough for scan-direct unilateral neck exploration. Br J Surg 1996;83:989-91.
20. Foldes I, Levay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m-pertechnetate and technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1993;20:330-3.
21. Rubello D, Mazzarotto R, Casara D. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma. Eur J Nucl Med 2000;27:431-40.
22. Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med 2001;83:989-91.
23. Rubello D, Casara D, Shapiro B. Recent advances in preoperative and intraoperative nuclear medicine procedures in patients with primary hyperparathyroidism. Panminerva Med 2002;44:99-105.
24. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801-7.
25. Bonjer HJ, Bruining HA, Pols HAP, de Herder WW, Eijck CH, Breeman WA et al. Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancer. Eur J Nucl Med 1997;24:246-51.
26. Jaskowiak NT, Sugg SL, Helke J, Kota MR, Kaplan EL. Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 2002;137:659-69.
27. Casara D, Rubello D, Cauzzo C, Pelizzo MR. 99mTc-MIBI radio-guided minimally invasive parathyroidectomy: experience with patients with normal thyroids and nodular goiters. Thyroid 2002;12:53-61.
28. Prager GP, Czerny C, Kurtaran A, Passler C, Scheuba C, Bieglmayer C et al. Minimally invasive open parathyroidectomy in an endemic goiter are. Arch Surg 2001;136:810-6.
29. dell'Erba L, Baldari S, Borsato N, Bruno G, Calo-Gabrieli C, Carletto M et al. Retrospective analysis of the association of nodular goiter and primary and secondary hyperparathyroidism. Eur J Endocrinol 2001;145:429-34.
30. Sfakianakis GN, Irvin GL, Foss J, Mallin W, Georgiou M, Deriso GT et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 1996;37:798-804.
31. Carty SE, Worsey MJ, Virji MA, Brown ML, Watson CG. Concise parathyroidectomy: the impact of preoperative STECT 99mTc sestamibi scanning and intraoperative quick parathyroid hormone assay. Surgery 1997;122:1107-16.
32. Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001;28:1351-9.
33. Rubello D, Piotto A, Casara D, Muzzio PC, Shapiro B, Pelizzo MR. Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: optimization of preoperative and intraoperative procedures. Eur J Endocrinol 2003;149:7-15.
34. Rubello D, Pelizzo MR, Casara D. Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage. Eur J Nucl Med Mol Imaging 2003;30:189-2.
35. Perrier ND, Ituarte PHG, Morita E, Hamill T, Gielow R, Duh QY et al. Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab 2002;87:1024-9.
36. Casara D, Rubello D, Piotto A, Pelizzo MR. 99mTc-MIBI radioguided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med 2000;27:1300-4.
37. Rubello D, Casara D, Giannini S, De Carlo E, Muzzio PC, Pelizzo MR. Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low 99mTc-MIBI dose: technical considerations and long-term clinical results. Q J Nucl Med 2003;47:129-38.
38. Leslie WD, Dupont JO, Bydel B, Riese KT. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase wash-out. Eur J Nucl Med 2002;29:1566-70.
39. Flynn MB, Bumpouns JM, Schill K, McMasters KM. Minimally invasive radioguided parathyroidectomy. J Am Coll Surg 2000;191:24-31.
40. McGreal G, Winter DC, Sookhai S, Evoy D, Ryan M, O'Sullivan GC et al. Minimally invasive, radioguided surgery for primary hyperparathyroidism. Ann Surg Oncol 2001;8:856-60.
41. Rubello D, Piotto A, Pagetta C, Pelizzo MR, Casara D. Ectopic parathyroid adenomas located at the carotid bifurcation: the role of preoperative Tc-99m MIBI scintigraphy and the intraoperative gamma probe procedure in surgical treatment planning. Clin Nucl Med 2001;26:774-6.
42. Miccoli P, Berti P, Matterazzi G, Donadini G. Minimally invasive assisted parathyrodiectomy (MIVAP). Eur J Surg Oncol 2003;29:188-90.
43. Fahy BN, Bold R, Beckett L, Scheider PD. Modern parathyroid surgery. A cost-benefit analysis of localizing strategies. Arch Surg 2002;137:917-23.
44. Dackiw AP, Sussman JJ, Fritsche HA Jr, Delpassand ES, Stanford P, Hoff A et al. Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 2000;135:550-5; discussion 555-7.
45. Udelsman R, Donovan PI, Sokoll LJ. One hundred consecutive minimally invasive parathyroid explorations. Ann Surg 2000;232:331-9.
46. Inabnett III WB, Dakin GF, Haber RS. Targeted parathyroidectomy in the era of intraoperative parathormone monitoring. World J Surg DOI: 10.10007/s00268-002-6619-7.
47. Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 1999;126:1023-9.
48. Rubello D, Casara D, Pelizzo MR. Symposium on parathyroid localizing imaging. Optimization of peroperative procedures. Nucl Med Commun 2003;24:133-40.
49. Norman J, Denham D. Minimally invasive radioguided parathyroidectomy in the reoperative neck. Surgery 1998;124:1088-93.
50. Henry JF, Iacobone M, Mirallie E, Deveze A, Pili S. Indications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism. Surgery 2001;130:999-1004.
51. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002;235:665-72.
52. Rubello D, Pelizzo MR, Gross MD, Fig LM, Shapiro B, Rampin L, Mariani G. Controversies on minimally invasive procedures for radioguided surgery of parathyroid tumors. Minerva Endocrinol 2004;29: 189-93.
53. Rubello D, Ruffini V, De Carlo E, Martini C, Calcagni ML, Sicolo N et al. New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues. Minerva Endocrinol 2003;28:259-96.
54. Lee NC, Norton JA. Multiple-gland disease in primary hyperparathyroidism. A function of operative approach ? Arch Surg 2002;137:896-900.
55. Denham DW, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyrodism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg 1998;186:293-304.
56. Solomon BL, Schaaf M, Smallridge RC. Phycologic symptoms before and after parathyroid surgery. Am J Med 1994;96:99-100.
57. Bilezikian JP, Potts JT jr, Fuleihan GEH, Kleerekoper M, Neer R, Peacock M et al. Summery Statement from a Workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st Century. J Clin Endocrinol Metab 2002;87:5353-61.